Wednesday, September 30, 2015

Shuttered Compounder Warned Over Sterility Issues

Despite having been closed for more than a year with no plan to reopen, the FDA issued a warning letter to Specialty Medicine Compounding Pharmacy for a litany of cGMP violations, including poor sterile processing controls.

To View This Article:


No comments: